Download Citation
Article Source:
Impact of combining the progesterone receptor and preoperative endocrine prognostic index (PEPI) as a prognostic factor after neoadjuvant endocrine therapy using aromatase inhibitors in postmenopausal ER positive and HER2 negative breast cancer
Kurozumi S,
Matsumoto H,
Inoue K,
Tozuka K,
Hayashi Y,
et al.
(2018)
Impact of combining the progesterone receptor and preoperative endocrine prognostic index (PEPI) as a prognostic factor after neoadjuvant endocrine therapy using aromatase inhibitors in postmenopausal ER positive and HER2 negative breast cancer.
PLOS ONE 13(8): e0201846.
https://doi.org/10.1371/journal.pone.0201846